Send us a text
Why aren't GLP-1 medications working for everyone?
You may be frustrated that semaglutide or tirzepatide isn't helping you lose weight like it has for others. The problem might not be your diet or willpower - it could be genetic.
Discover how a single gene called TCF7L2 may be sabotaging your weight loss efforts with GLP-1 medications, and what you can do about it.
BY THE TIME YOU FINISH LISTENING, YOU'LL DISCOVER:
- Why 10-15% of people may be "non-responders" to GLP-1 agonists for weight loss
- The gene that could impact the effectiveness of GLP-1
- Strategies to overcome genetic resistance to GLP-1 medications
This episode could be a game-changer if you've been struggling with weight loss despite using GLP-1 agonists.
RESEARCH ARTICLES:
- Efficacy And Safety Of Semaglutide For Weight Loss In Adults With Overweight Or Obesity
- A review of receptor interactions and co-stimulation, Peptides
- Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
Support the show
✨ Ready to take today’s insights and put them into action?
WANT AN ELEVATED APPROACH TO YOUR HEALTH?
- Precision Wellness Consult – Discover how your DNA unlocks energy & vitality [Apply Here].
- Preview A Genomic Report – See a sample [Preview Here].
- Join Our Inner Circle – Connect with high-achieving women [Join Here].
FOR PRACTITIONERS & HEALTH PROFESSIONALS
- Unlock the Blueprint Masterclass – Learn to tailor wellness [Register Here].
- Refer With Confidence – Explore partnership opportunities [Schedule Here].
FOLLOW DR. TAMAR LAWFUL
[Instagram] | [LinkedIn] | [TikTok]
ENJOYED THIS EPISODE?
Share with a friend & leave a 5-star Apple Review Hereor [Here].
